The Claim
Extended-release iron tablets have significantly higher iron bioaccessibility (19.31%) during simulated digestion compared to conventional iron tablets, indicating that pharmaceutical formulation design determines the amount of iron released in the gastrointestinal tract.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Extended-release iron tablets release more usable iron during digestion than regular iron tablets, and this difference is due to how the tablets are designed.
See the scientific wording
Extended-release iron tablets exhibit significantly higher iron bioaccessibility (19.31%) than conventional tablets (lowest among formulations), suggesting that pharmaceutical formulation design influences the amount of iron released during simulated digestion.
Iron tablets designed to release slowly avoid rapid breakdown in the stomach, allowing iron to reach the small intestine gradually. This prevents iron from turning into a form that cannot dissolve in the alkaline environment of the intestine. The steady release keeps iron in a soluble state that can be absorbed by cells lining the intestine.
What the research says
1 studyScientists tested different kinds of iron pills in a lab that mimics the stomach and intestines, and found that pills designed to release iron slowly gave off more iron than regular pills. This means the way the pill is made really affects how much iron your body can use.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.